SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
8-K	Jan 9, 2017	8-K
8-K	Dec 22, 2016	8-K
4	Dec 20, 2016	PRIMARY DOCUMENT
8-K	Dec 1, 2016	8-K
4	Nov 15, 2016	PRIMARY DOCUMENT
3	Nov 15, 2016	PRIMARY DOCUMENT
10-Q	Nov 9, 2016	10-Q
8-K	Nov 9, 2016	8-K
8-K	Nov 3, 2016	8-K
8-K	Oct 31, 2016	8-K
8-K	Oct 26, 2016	8-K
424B3	Oct 20, 2016	424B3
EFFECT	Oct 19, 2016
CORRESP	Oct 17, 2016
S-3/A	Oct 14, 2016	S-3/A
CORRESP	Oct 14, 2016
UPLOAD	Oct 14, 2016
424B3	Oct 12, 2016	424B3
EFFECT	Oct 11, 2016
S-3/A	Oct 11, 2016	S-3/A
8-K	Oct 6, 2016	8-K
CORRESP	Oct 6, 2016
S-3	Sep 30, 2016	FORM S-3
CORRESP	Sep 28, 2016
S-3/A	Sep 28, 2016	S-3/A

← Newer Page 24 of 51 · 1272 filings Older →